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periodontal disease is clearly correlated with systemic disease. the presence of periodontal pathogens 
in interdental spaces in young, healthy adults is a strong indicator of the need to introduce daily 
interdental prophylaxis. Twenty-five subjects (aged 18–35 years), diagnosticated clinically as 
periodontally healthy, were enrolled in this study. one hundred interdental sites were included. Among 
these sites, 50 “test” sites were cleaned daily with calibrated interdental brushes (IDBs), whereas the 
other 50 sites were not cleaned and considered “controls”. The interdental biofilm at these interdental 
sites was collected at the beginning of the study (basal) and at 1 week, 2 weeks, 3 weeks, 4 weeks, 
and 3 months. Real-time polymerase chain reaction (PCR) methodology was used to quantify (i) 
19 periodontal bacteria, including Porphyromonas gingivalis, Treponema denticola, and Tannerella 
forsythia, and (ii) total bacteria. In the test sites, the quantity of total bacteria decreased over time with 
the use of IDBs. The bacteria from the red and orange Socransky complexes, which are associated with 
periodontal disease, significantly decreased in the test sites but not in the control sites. Bacteria from 
the yellow, and purple Socransky complexes, which are associated with periodontal health, increased 
significantly in both groups whereas bacteria from the blue Socransky complex increased significantly 
only in the test sites. Furthermore, at basal, 66% of test sites and 68% of control sites bled during 
interdental brushing. These percentages decreased by 85% in 3 months for the test sites and by 27% 
in the control sites. in conclusion, the daily use of calibrated iDBs can reduce periodontal pathogens, 
reestablish symbiotic microbiota and, decrease interdental inflammation in interdental sites of healthy 
young adults.
Periodontal disease (ICD-10 KO5.3), with a prevalence estimated at 750 847 000 cases in 195 countries and 
territories1, is an oral infectious disease caused by complex interactions between the microbial biofilm and host 
immune responses2. Periodontal pathogens can enter the host system through daily bacteremia following break-
down of epithelial and endothelial barriers due to the host’s inflammatory responses and the ability of some 
pathogens to attack these barriers3. However, the importance of oral-systemic connection is not only due to the 
implication of periodontal pathogens in the pathogenesis of periodontitis and systemic diseases. The presence 
of periodontal pathogens and their metabolic by-products in the mouth may modulate the immune response 
beyond the oral cavity, thus promoting the development of systemic inflammation and thus systemic disease4.
Periodontal disease exhibits an association with multiple systemic diseases, such as cardiovascular disease 
(including atherosclerosis, stroke, hypertension, myocardial infarction, and congestive heart failure), rheumatoid 
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arthritis, inflammatory bowel disease and colorectal cancer, respiratory tract infection, type 2 diabetes mellitus, 
and respiratory tract infection5–7. From a clinical point of view, it is evident that the prevention of periodontal 
disease strategies directed at keystone pathogens could have a major effect on the incidence and progression of 
systemic disease8.
Periodontal pathogens were categorized into color-coded complexes based on their role in periodontal 
pathogenesis9. Red complex bacteria (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia) 
are the major etiologic agents that contribute to a high risk of chronic periodontitis by modulating the host 
inflammatory response10. Orange complex bacteria, including Fusobacterium nucleatum, Prevotella intermedia, 
Prevotella nigrescens, Parvimonas micra, Eubacterium nodatum, and various Campylobacter species, are classified 
as moderate risk11. Blue (Actinomyces viscosus, etc.), yellow (Streptococcus mitis, Streptococcus spp., etc.), green 
(Aggregatibacter actinomycetemcomitans, Campylobacter concisus, Capnocytophaga ochracea, Capnocytophaga 
sputigena, Eikenella corrodens, etc.), and purple (Actinomyces odontolyticus, Veillonella parvula, etc.) complexes 
are compatible with periodontal health9.
In 2016, pathogens were identified in interdental spaces in young adults with healthy periodontium. P. gingiv-
alis was detected in 19%, T. denticola in 49%, and T. forsythia in 93% of healthy young adults, whereas pathogens 
from the orange complex were detected in at least 81% of these subjects. The major explanation is that interdental 
spaces are a unique and real ecological niche, for which the body has few or no alternative defenses and where 
traditional daily hygiene methods are not adequate for disrupting biofilm12.
This effective presence of virulent pathogens in healthy young adults is a strong indicator of the need to initiate 
new methods for disrupting interdental biofilm in daily oral hygiene. Recently, the study of Duval and colleagues 
has suggested that the “everyday low-level bacteremia” that occurs after toothbrushing, flossing, interdental 
brushing or chewing could also potentially pose risk to endocarditis13. Therefore, the use of interdental brushes 
(IDBs) could represent a serious alternative to reduce the level of virulent bacteria and to optimize the disruption 
of biofilms. To our knowledge, no randomized controlled clinical trial has shown the microbiological impact of 
calibrated IDBs on the interdental virulent microbiota in healthy adults. The aim of the present study was there-
fore to determine the bacterial efficacy of the use of calibrated IDBs on red and orange complex bacteria in young 
adults without chronic periodontal complaints.
Methods
Study design. The workflow of the impact of interdental brushing on the evolution of interdental biofilm 
(BACTERIB) is described in Fig. 1.
Study population. This study included 25 Caucasian adults aged 20 to 35 years old. Subjects were recruited 
from a pool of first-time volunteers who were referred to the Department of Public Health of the Faculty of Oral 
Medicine at the University of Lyon, France. All participants signed an informed consent form in accordance 
with the Declaration of Helsinki. The study protocol was reviewed and approved by the Local Ethics Committee 
“University Hospital Center of Lyon” (Rech_FRCH_2015-0181) and by the National Commission of Informatics 
and Liberties, France (1845681v0). This study was retrospectively registered with ClinicalTrials.gov (identifica-
tion number: NCT03714295).
Subjects were included if they were aged between 20 and 35 years, in good general health, not pregnant or 
breastfeeding, and periodontally healthy and if they had no health conditions that required antibiotic prophylaxis 
before interproximal probing, no experience with interdental cleaning (interdental brushing or dental flossing), 
and no intake of systemic antimicrobials during the previous 6 months. To be included, the subjects had to brush 
their teeth at least twice per day, not use chlorhexidine or over-the-counter mouthwash, have no implants or 
orthodontic appliances, have no previous periodontal illness or treatment history, have at least 24 natural teeth, 
have 4 premolar-molar pairs, be non-smokers, and have a willingness to return 3 weeks after the clinical investi-
gation for microbiological tests.
The clinical inclusion criteria for each premolar-molar interdental site were as follows: (i) accessibility to 
the interdental space of the 4 sites (15–16, 25–26, 35–36, and 45–46) by an interdental brush in each subject; 
(ii) no interproximal caries or dental or prosthetic restorations; (iii) no interdental diastema; (iv) no clinical 
signs of inflammation, such as redness, swelling; (v) no pocket depth (PD) > 3 mm or clinical attachment loss 
(CAL) > 3 mm; and (iv) the subjects were judged to be free of gingivitis or periodontitis.
Subjects were excluded if they had missing teeth due to periodontal issues, any other concomitant systemic 
disorder, diseases affecting the immune system, and use of medications, such as anti-platelet or anti-coagulant 
agents. The patients submitted to professional prophylaxis 4 weeks prior to the baseline examination; patients 
with previous periodontal disease or treatment or who were undergoing a course of dental or orthodontic treat-
ment were also excluded.
Classification of subjects as periodontally healthy. The diagnosis of periodontally healthy was made 
according to the American Academy of Periodontology14, with some modifications15. The patients were scored 
for PD, CAL, and BOP. The studied group was composed of individuals who presented with clinically healthy 
periodontal tissues (PD ≤ 3 mm, CAL < 3 mm and ≤10% of sites with BOP after 30 s). Clinical assessments of 4 
interdental sites (15–16, 25–26, 35–36, and 45–46) were performed using an IAP CURAPROX colorimetric probe 
(Curaden, Kriens, Switzerland) (Supplementary Fig. 1). The diameter and bleeding upon interdental brushing 
(BOIB) were recorded16.
clinical examination. Standardized clinical monitoring was performed three weeks before the microbio-
logical monitoring. The subjects were submitted to a medical/dental anamnesis, and information regarding their 
age, gender and smoking status was obtained. The clinical measurements were performed at 6 sites per tooth 
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(mesio-buccal, buccal, disto-buccal, disto-lingual, lingual, and mesio-lingual) on all teeth, except for the third 
molars, as previously described17. The clinical parameters were measured in the following order: PD (mm), CAL 
(mm), and BOP after 30 s (0 or 1). The full-mouth clinical measurements included BOP, PD and CAL, which were 
recorded using a North Carolina periodontal probe (Hu-Friedy, Chicago, IL, USA).
The clinical assessments of the interdental spaces were performed using an IAP CURAPROX© colorimetric 
probe (Curaden, Kriens, Switzerland). The diameter of all interdental spaces of 4 teeth (premolar-molar) was 
measured to determine the calibrated IDB (diameter of the IDB corresponding to the interdental space diame-
ter). Subjects received IDBs (Curaprox CPS; Curaden) of sizes corresponding to the diameter of their interdental 
spaces. The first use of the product was conducted under the supervision of a qualified public health professor. 
The instruction comprised verbal instructions on interdental brushing supported by practical demonstration. 
No further oral-hygiene instructions were provided. All other brushings were unsupervised, and the participants 
were required to maintain a diary card. Subjects were instructed to mark the box corresponding to the current 
date on the diary card every evening after performing their interdental brushing to ensure that brushing was 
performed every day. Moreover, the participants were instructed to brush their teeth 3 hours before the sampling 
visit and not to drink, eat or practice oral hygiene during this period.
interdental site randomization. For each patient, 4 interdental sites localized between premolar-molar 
(15–16, 25–26, 35–36, and 45–46) were studied. Among these 4 sites studied, 2 were designed as test sites and 2 
were designed as control sites. The test sites (2 per patient, total n = 50) and the control sites (2 per patient, total 
n = 50) were randomized symmetrical on each upper and lower arch (Table 1). One test site and one control site 
were in the upper jaw and even at the level of the mandible. Patients were instructed to brush their teeth twice a 
day for 2 min, rinse with water. In the test sites after brushing their teeth, patients were trained to use calibrated 
interdental brushes for a single cleaning movement once a day (in the evening) only. No other product or oral 
hygiene technique was allowed.
Figure 1. Workflow of the experiment. BOIB: Bleeding on Interdental Brushing; BOP: Bleeding on Probing; 
CAL: Clinical Attachment Loss; IDB: Interdental Brush; PD: Probing Depth.
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interdental sample collection and microbiological analysis by real-time polymerase chain reac-
tion. At each clinical examination, the same four interdental sites (15–16, 25–26, 35–36, and 45–46) were 
studied (total of 100 sites) in all subjects. Based on the clinical assessment of the interdental spaces, the examiner 
selected the appropriate CPS prime interdental brushes (Curaden, Kriens, Switzerland)18. He isolated each pre-
viously selected tooth with sterile cotton rolls, and removed the interdental biofilm with a sterile, calibrated IDB. 
For each sample, he placed the IDBs in 1.5 mL sterile microcentrifuge tubes and stored at 4 °C for further process-
ing. Then, the examiner recorded the BOIB16. For the test sites, the collection was performed at the following six 
time points: at baseline, 1, 2, 3, and 4 weeks and 3 months; for the control sites, the collection was not performed 
at 2, 3, and 4 weeks to avoid perturbations due to the introduction of the IDB for the sampling.
The total DNA was extracted using QIAcube HT Plasticware and a Cador Pathogen 96 QIAcube HT Kit 
(Qiagen, Hilden, Germany) according to manufacturer’s guidelines. The DNA was eluted in 150 µL. DNA quanti-
ties and quality were determined with an ultraviolet spectrophotometer at 260 nm and 280 nm.
Real-time polymerase chain reaction (PCR) was used to detect and quantify the total bacterial load (TB) 
and 19 periodontal pathogens (red complex: P. gingivalis, T. forsythia, T. denticola; orange complex: C. gracilis, 
C. rectus, F. nucleatum, P. intermedia, P. micra, P. nigrescens; yellow complex: S. mitis, Streptococcus spp.; green 
complex: E. corrodens, C. sputigena, C. ochracea, C. concisus, A. actinomycetemcomitans; purple complex: V. par-
vula, A. odontolyticus; and blue complex: A. viscosus) in interdental biofilms. Real-time PCR was performed as 
previously described by Carrouel and colleagues12. The sequences of universal primers for the 16S rRNA genes 
and species-specific primer sets used are shown in the Supplementary Table 1.
For each sample, simplex quantitative PCR (qPCR) was performed in a total volume of 10 µL using qPCR 
kit (1 × SYBR® Premix Ex TaqTM Tli RNaseH Plus, TaKaRa, Shiga, Japan), which contained 2 μL of the template 
DNA and 1 µM of each primer. A Rotor-Gene® Q thermal cycling system (Qiagen, Hilden, Germany) was used to 
performed the assays. The cycle for each sample was the following program: 95 °C for 30 s, followed by 40 cycles 
of 10 s at 95 °C, 10 s at the annealing temperature (Supplementary Table 1), and 35 s at 72 °C. A final melting curve 
analysis (70 °C to 95 °C in 1 °C steps at 5 s increments) was performed. For every cycle, at the end of the extension 
step and continuously during the melting curve analysis, the fluorescence signal was measured. The Rotor-Gene® 
Q Series software (Qiagen, Hilden, Germany) was used to analyze the data.
Serial dilutions of a bacterial standard DNA provided by Institut Clinident SAS (Aix en Provence, France) 
were used in each reaction as external standards for the absolute quantification of the targeted bacterial path-
ogens. The standard bacterial strains came from BCMM/LMG Bacteria Collection, CIP Collection of Institut 
Pasteur, or from DSMZ (Germany): Aa (DSM No. 8324), Ao (DSM No. 43760), Av (DSM No. 43327), Cc (DSM 
No. 9716), Cg (DSM No. 19528), Co (DSM No. 7271), Cr (LMG No. 7613), Cs (DSM No. 7273), Ec (DSM No. 
8340), Fn (DSM No. 20482), Pg (DSM No. 20709), Pi (DSM No. 20706), Pm (DSM No. 20468), Pn (DSM No. 
13386), Smitis (DSM No. 12643), Sspp (Streptococcus mitis DSM No. 12643), Td (DSM No. 14222), Tf (CIP No. 
105220), and Vp (CIP No. 60.1). The Supplementary Table 1 details the limit of quantification (LOQ).
Statistics. The statistical analysis consisted of three main steps, namely, producing descriptive summaries 
of the data, modeling the data using a mixed (linear) model and assessing the correlations between the bacterial 
abundances. Descriptive statistics (percentages, means and standard deviations) were calculated with SPSS 12.0 
(SPSS Inc., Chicago, IL). The statistical tests (p-values) were calculated with SUDAAN 7.0 (Research Triangle 
Institute, Research Triangle Park, NC) to account for clustering (multiple sites within the mouth) and repeated 
measures (measurements along the follow-up period). Statistical methods are clearly indicated in table footnotes. 
All data were considered statistically significant at p < 0.05.
Results
periodontal parameters in the patients. The study sample was composed of 10 females and 15 males 
(Table 2). The clinical parameters confirmed that subjects were periodontally healthy. A comparison of the test 
sites with the control sites revealed similar scores for BOP, PD, CAL and ID diameter (p > 0.05).
evolution of interdental bleeding. The bleeding during interdental brushing decreased by 47% after one 
week of the daily use of IDBs and 85% after 3 months in the test sites, whereas no significant change was observed 
in the control sites (Fig. 2 and Table 3).
Quantitative analysis of socransky’s complexes. Table 4 shows that bacteria from the green, orange 
and red Socransky complexes were significantly decreased over time in subjects using IDBs, in contrast to subjects 
not using IDBs. Bacteria from the blue complex significantly increased in the test sites but not in the control sites, 
whereas bacteria from the purple, and yellow complexes increased in both type of sites. The main differences 
between groups up to 3 months are on orange and red complexes.
Quadrant Control sites Test sites Total of sites
1 12 13 25
2 13 12 25
3 13 12 25
4 12 13 25
Total of sites 50 50 100
Table 1. Repartition of Sites (n = 100a) According to the Quadrant. a25 patients with 1 site by quadrant (4 sites 
by patients).
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Figure 3 and Table 5 show that the daily use of IDBs makes it possible to significantly reduce the number of 
orange and red complex bacteria in as little as a week, except for P. micra and P. gingivalis. The quantity of P. micra 
is significantly reduced after 3 weeks of daily IDB use, while for P. gingivalis, it takes 4 weeks.
Table 6 confirms that the daily use of IDBs impacts the number of bacteria from the orange and red complexes 
at 4 weeks and 3 months, whereas no significant differences were observed at baseline.
The results from the multiple regression models (Table 7) indicate that the use of IDBs, the quantity of bac-
teria at T0, the age and the IDB diameter at 3 months have a significant statistical effect on the quantity of some 








Teeth 28.9 ± 1.2
Full mouth
BOP (%) 0.16 ± 0.08
PD (mm) 0.95 ± 0.21
CAL (mm) 0.95 ± 0.21
Sampled sites Test Sites Control Sites
BOP (%) 0.10 ± 0.02 0.10 ± 0.01 ≈1
PD (mm) 1.37 ± 0.28 1.32 ± 0.23 ≈1
CAL (mm) 1.60 ± 0.41 1.58 ± 0.40 ≈1
ID diameter
0.6 mm, n (%) 1 (2.0) 2 (4.0)
0.7 mm, n (%) 12 (24.0) 28 (56.0)
0.8 mm, n (%) 21 (42.0) 12 (24.0)
0.9 mm, n (%) 12 (24.0) 5 (10.0)
1.1 mm, n (%) 4 (8.0) 3 (6.0)
mean ± sd (mm) 0.76 ± 0.12 0.76 ± 0.11 ≈1
Table 2. Baseline Clinical Features of the Subjects, Test Sites, and Control Sites. The values are 
means ± standard deviations. BOP: Bleeding On Probing; CAL: Clinical Attachment Level; ID: Interdental; PD: 
Pocket Depth. aBy SUDAAN 7.0. 
Figure 2. Evolution of interdental bleeding over time. The results are expressed as the percentage of the 50 
test (daily use of calibrated interdental brushes) or 50 control (no use of interdental brushes) sites presenting 
bleeding on interdental brushing. *p-value < 0.05 for pairwise comparison vs T0.
Basal (T0) 4 weeks (T4) 3 months (T5)
Test sites 68% 8% 10%
Control sites 66% 50% 48%
Table 3. Evolution of Interdental Bleeding in the Test and Control Sites. The results are expressed as the 
percentage of active or control sites that bled compared to the total of active or control sites.
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Discussion
There is currently, no clinical research trial evaluating interdental prophylaxis options in clinically healthy young 
adults in relation to the presence of highly virulent periodontal bacteria. Effectively, only two studies compared 
toothbrushing plus interdental brushing to toothbrushing alone and reported data at one month. Both were at 
risk of bias19. Outcomes measured gingivitis by gingival index and by proportion of bleeding sites20,21. Moreover, 
Graziani and colleagues measured periodontitis but no data were reported20. So, prophylactic options are empir-
ical and mainly arise from the experiences obtained during mechanical or surgical treatment of clinical perio-
dontitis22. Our study is a Randomised Controlled Trials that compared a home-use interdental cleaning device 
and toothbrushing versus toothbrushing alone (duration 3 months) with an outcome variable, the quantitative 
evolution of periodontal bacteria. The results indicate that the daily use of calibrated IDBs, especially compared 
to simple toothbrushing, modifies the composition of interdental microbiota that becomes symbiotic and reduces 
interdental inflammation.
Periodontitis are multifactorial oral disease mainly due to bacteria and more particularly to the dysbiosis 
of the oral microbiota23. The symbiotic host-microbe relationship gradually changing to a pathogenic one. The 
periodontal health deteriorates until a state of clinical disease occurs. Simultaneously, a succession of microbial 
complexes develops. The biofilm associated with healthy mouth, mainly localised to enamel surfaces and oral 
mucosa, is composed of gram-positives aerobic bacteria such as bacteria from the blue, yellow, green, and purple 
complexes24. As undisturbed biofilm matures, the biofilm population changes to a predominately gram-negative 
anaerobic microbiota. Bacteria from the orange complex progressively adhere followed by bacteria from the 
red complex which are considered as “keystone pathogens”25. These periodontal pathogens are able to exploits 
complement-TLR crosstalk to subvert host defences and escape elimination. This defective immune monitoring 
results in a change in the biofilm composition (dysbiosis) that causes inflammatory periodontitis26.
Effective oral hygiene is crucial for maintaining good oral health, which is associated with global health5. 
Inside the oral sphere, the interdental gingiva, which is composed of the facial and lingual papillae and the col, 
is a unique area anatomically and histologically. The gingival stratified epithelia act as a barrier that serves to 
protect the internal tissues from environmental stresses, chemical damage, bacterial infection and antimicrobial 
protection. Moreover, the gingival col in the interdental space is not enhanced by keratinization27,28. In addition 
to the direct tissue destructive properties, some subgingival bacteria have different abilities to inhibit and interact 


















Total bacteria 10.08 ± 0.38 9.85 ± 0.42* 9.77 ± 0.53* 10.00 ± 0.39 10.05 ± 0.46 10.02 ± 0.51
Socransky’s Blue (Actinomyces viscosus) 0.77 ± 1.41 0.82 ± 1.28 1.35 ± 1.85* 0.63 ± 1.29 0.42 ± 0.97 1.24 ± 1.77
Socransky’s Purple 5.75 ± 0.69 6.50 ± 0.52* 6.75 ± 0.63* 5.67 ± 0.70 6.32 ± 0.62* 6.68 ± 0.59*
   Veillonella parvula 5.66 ± 0.74 6.45 ± 0.55* 6.74 ± 0.63* 5.55 ± 0.77 6.29 ± 0.64* 6.66 ± 0.58*
   Actinomyces odontolyticus 4.27 ± 1.23 4.95 ± 0.68* 4.33 ± 1.86* 4.10 ± 1.47 4.52 ± 1.14 4.40 ± 1.49
Socransky’s Green 6.80 ± 0.75 6.52 ± 0.99* 6.25 ± 0.83* 6.74 ± 0.80 6.61 ± 0.91 6.82 ± 0.94
   Eikenella corrodens 6.44 ± 0.98 6.08 ± 1.39* 5.73 ± 1.22* 6.20 ± 1.38 5.82 ± 1.38* 5.46 ± 1.56*
   Capnocytophaga sputigena 5.03 ± 1.05 5.17 ± 1.90 4.86 ± 1.90 4.89 ± 1.23 4.63 ± 2.02 4.68 ± 1.75
   Capnocytophaga ochracea 5.78 ± 1.30 4.45 ± 2.40* 4.72 ± 2.04* 5.66 ± 1.45 5.34 ± 2.03 5.21 ± 1.82
   Campylobacter concisus 3.23 ± 1.54 3.46 ± 1.80 3.51 ± 1.31* 3.16 ± 1.47 3.58 ± 1.62* 3.79 ± 1.34*
   Aggregatibacter actinomycetemcomitans 0.24 ± 1.21 0.35 ± 1.44 0.28 ± 1.14 0.50 ± 1.70 0.61 ± 1.90 0.53 ± 1.65
Socransky’s Yellow 6.29 ± 0.57 6.58 ± 0.47* 6.61 ± 0.75* 6.16 ± 0.58 6.46 ± 0.53* 6.46 ± 0.66*
   Streptococcus mitis 5.09 ± 0.75 5.10 ± 0.77 5.22 ± 0.73 4.94 ± 0.73 4.81 ± 0.85 5.02 ± 0.77
   Streptococcus spp. 6.25 ± 0.56 6.55 ± 0.47* 6.58 ± 0.76* 6.13 ± 0.57 6.44 ± 0.53* 6.43 ± 0.67*
Socransky’s Orange 7.80 ± 0.48 7.16 ± 0.76* 7.05 ± 0.87* 7.71 ± 0.48 7.73 ± 0.54 7.61 ± 0.63
   Campylobacter gracilis 4.79 ± 1.08 3.77 ± 1.76* 3.72 ± 1.70* 4.77 ± 0.97 4.88 ± 0.73 4.51 ± 1.33
   Campylobacter rectus 6.41 ± 1.89 5.77 ± 1.68* 5.88 ± 1.18* 6.54 ± 1.37 6.91 ± 2.06 6.77 ± 2.18
   Prevotella intermedia 5.63 ± 2.76 3.88 ± 2.86* 4.18 ± 2.73* 5.47 ± 2.87 4.78 ± 2.89 5.06 ± 2.72
   Prevotella nigrescens 3.94 ± 1.62 1.16 ± 1.80* 1.07 ± 1.81* 3.92 ± 1.78 3.66 ± 1.98 3.02 ± 2.02
   Parvimonas micra 5.30 ± 1.98 4.41 ± 2.50* 4.99 ± 2.04 4.94 ± 2.21 4.79 ± 2.21 5.06 ± 2.17
   Fusobacterium nucleatum 7.57 ± 0.36 7.01 ± 0.77* 6.85 ± 0.95* 7.45 ± 0.35 7.51 ± 0.50 7.47 ± 0.61
Socransky’s Red 6.02 ± 2.11 3.63 ± 2.62* 4.13 ± 2.45* 5.89 ± 1.86 5.54 ± 2.07 5.29 ± 2.42
   Porphyromonas gingivalis 1.17 ± 2.50 0.89 ± 1.01* 0.76 ± 0.62* 1.11 ± 2.47 1.04 ± 2.14 0.99 ± 2.06
   Tannerella forsythia 5.75 ± 1.93 3.43 ± 2.39* 3.58 ± 2.47* 5.66 ± 1.72 5.31 ± 1.88 5.22 ± 2.36
   Treponema denticola 3.47 ± 3.47 1.78 ± 2.82* 2.59 ± 3.02* 3.02 ± 3.38 2.79 ± 3.40 2.50 ± 3.33
Table 4. Evolution of Bacteria in the Socransky Complexes in the Test and Control Sites. N: Number of 
interdental sites; *p-value < 0.05 for pairwise comparison vs T0 by SUDAAN 7.0 (procedure DESCRIPT) to 
account for clustering (multiple sites within the patient). The results are expressed as the mean ± standard 
deviation after Log conversion (Log10 (count + 1)) of bacterial counts.
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bacteria produce virulent factors that directly (enzymes and toxins) or indirectly (antigens and activators) induce 
an inflammatory response29–31. The virulence of bacteria depends on adhesion’s factor such as adhesins, lectins, 
fimbriae and vesicles. Moreover, periodontal bacteria produce agents that damage the periodontal tissues such 
as proteases, alkali and acid phosphatases, fatty and organic acids, igG- and igA-proteases, chondroitinsulfatase 
and toxic products (endotoxins, leukotoxin, mucopeptides of the bacterial wall, end-products of metabolism such 
Figure 3. Evolution of the abundance of bacterial species over time in the test sites. The counts are reported on 
a log10 scale. Each box represents the first quartile, median quartile, and third quartile, from bottom to top. The 
box colors represent the colors of the Socransky complexes. *p-value < 0.05 for pairwise comparison vs T0 by 
SUDAAN 7.0 (procedure DESCRIPT) to account for clustering (multiple sites within the patient).
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as H2S, NH4, indole). All anatomical and physiological conditions are gathered for dissemination in the body of 
virulent bacteria by breaking the microcirculatory bloodstream32.
This study demonstrated that the interdental biofilm in young adults with no signs of gingivitis or periodonti-
tis have all the characteristics favoring the chronic infection low-grade process. Inflammation has classically been 
viewed as an acute response to tissue injury that produces characteristic symptoms and usually resolves spontane-
ously. If the development of periodontal disease is a result of the concerted action of the total biofilm community, 
there is no biologically perfect state of health called “pristine gingiva”. Like the concept of para-inflammation 
developed in cancerology (Aran) i.e., a low-grade process identified with a gene signature, a para-inflammatory 
mechanism may be associated with periodontitis33–35. These proinflammatory instigators promote a perpetual 
low-level chronic inflammatory state36. Although it progresses silently, para-inflammation presents a major threat 
to the health and longevity of all aging humans.
Thus, by targeting the myriad of physiological variables that can elicit an inflammatory response, one can 
effectively prevent chronic inflammation and reduce the risk of inflammatory diseases. It is advantageous to keep 
bacterial reservoirs, such as those in the mouth, at the lowest levels possible to reduce the chances of the devel-
opment of infection and chronic diseases. Regardless of age and medical history, reduction in infectious risks by 
oral virulent bacteria should be a priority.
In this study, young adults with no signs of gingivitis or periodontitis housed bacteria from the Socransky 
complexes and more particularly from the red and orange complexes in their interdental spaces. This result is 
consistent with what we observed in our previous study12. The presence of these highly virulent periodonto-
pathogens is evidence of interdental dysbiotic microbiota. Although complex interactions between immune 
response mediators and biofilms are necessary for disease progression from gingivitis to periodontitis37, the host 
response is modified by dysbiotic microbiota, which provokes an inappropriate and uncontrolled level of inflam-
mation5. This local inflammation causes an increased flow of nutrient-rich gingival crevicular fluid and poten-
tially bleeding. Consequently, the inflamed site is deprived of oxygen, favoring the growth of anaerobic bacterial 
periodontopathogens38.
Moreover, in this study, healthy young adults with no clinical signs of gingivitis bleed when they use calibrated 
IDBs as we previously described12. They have inflammation in the interdental spaces, indicating that periodontal 
pathogens can penetrate the bloodstream39. Generally, oral bacteria are eliminated from the vascular system 
Bacteriaa
Time Comparisonb
Basal (T0) 1 week (T1) 2 weeks (T2) 3 weeks (T3) 4 weeks (T4) 3 months (T5)
Global 
p-value
Pairwise vs T0 
p<0.05
Total bacteria 10.08 ± 0.38 9.77 ± 0.33 9.69 ± 0.34 9.94 ± 0.47 9.85 ± 0.42 9.77 ± 0.53 <0.001 T1, T2, T4, T5
Socransky's Blue (Actinomyces viscosus) 0.77 ± 1.41 0.41 ± 0.95 0.43 ± 1.02 0.58 ± 1.20 0.82 ± 1.28 1.35 ± 1.85 <0.001 T5
Socransky's Purple 5.75 ± 0.69 5.36 ± 0.75 5.73 ± 0.56 5.54 ± 1.10 6.50 ± 0.52 6.75 ± 0.63 <0.001 T1, T4, T5
   Veillonella parvula 5.66 ± 0.74 5.08 ± 0.95 5.01 ± 1.20 5.10 ± 1.42 6.45 ± 0.55 6.74 ± 0.63 <0.001 T1, T2, T3, T4, T5
   Actinomyces odontolyticus 4.27 ± 1.23 4.27 ± 1.43 5.08 ± 1.25 4.72 ± 1.54 4.95 ± 0.68 4.33 ± 1.86 <0.001 T2, T4
Socransky's Green 6.80 ± 0.75 6.66 ± 0.81 6.60 ± 0.72 6.19 ± 0.85 6.52 ± 0.99 6.25 ± 0.83 <0.001 T3, T4, T5
   Eikenella corrodens 6.44 ± 0.98 6.51 ± 0.90 6.06 ± 1.19 5.25 ± 1.82 6.08 ± 1.39 5.73 ± 1.22 <0.001 T2, T3, T4, T5
   Capnocytophaga sputigena 5.03 ± 1.05 5.84 ± 1.67 5.02 ± 0.92 5.12 ± 1.84 5.17 ± 1.90 4.86 ± 1.90 0.068 —
   Capnocytophaga ochracea 5.78 ± 1.30 4.59 ± 1.80 4.30 ± 2.16 4.28 ± 2.27 4.45 ± 2.40 4.72 ± 2.04 <0.001 T1, T2, T3, T4, T5
   Campylobacter concisus 3.23 ± 1.54 3.28 ± 1.44 3.53 ± 1.54 3.43 ± 1.51 3.46 ± 1.80 3.51 ± 1.31 0.045 —
   Aggregatibacter actinomycetemcomitans 0.24 ± 1.21 0.36 ± 1.47 0.39 ± 1.38 0.33 ± 1.34 0.35 ± 1.44 0.28 ± 1.14 0.365 —
Socransky's Yellow 6.29 ± 0.57 6.65 ± 0.49 6.75 ± 0.36 6.90 ± 0.52 6.58 ± 0.47 6.61 ± 0.75 <0.001 T1, T2, T3, T4, T5
   Streptococcus mitis 5.09 ± 0.75 5.87 ± 0.45 5.71 ± 0.46 5.07 ± 0.88 5.10 ± 0.77 5.22 ± 0.73 <0.001 T1, T2
   Streptococcus spp. 6.25 ± 0.56 6.55 ± 0.52 6.69 ± 0.38 6.89 ± 0.52 6.55 ± 0.47 6.58 ± 0.76 <0.001 T1, T2, T3, T4, T5
Socransky's Orange 7.80 ± 0.48 7.05 ± 0.62 7.03 ± 0.65 6.82 ± 0.78 7.16 ± 0.76 7.05 ± 0.87 <0.001 T1, T2, T3, T4, T5
   Campylobacter gracilis 4.79 ± 1.08 3.67 ± 1.30 3.42 ± 1.44 3.67 ± 1.85 3.77 ± 1.76 3.72 ± 1.70 <0.001 T1, T2, T3, T4, T5
   Campylobacter rectus 6.41 ± 1.89 6.07 ± 1.72 5.61 ± 2.02 5.24 ± 1.93 5.77 ± 1.68 5.88 ± 1.18 <0.001 T1, T2, T3, T4, T5
   Prevotella intermedia 5.63 ± 2.76 4.23 ± 2.60 4.20 ± 2.80 3.34 ± 3.00 3.88 ± 2.86 4.18 ± 2.73 0.002 T1, T2, T3, T4, T5
   Prevotella nigrescens 3.94 ± 1.62 0.66 ± 1.28 0.53 ± 1.09 0.80 ± 1.56 1.16 ± 1.80 1.07 ± 1.81 <0.001 T1, T2, T3, T4, T5
   Parvimonas micra 5.30 ± 1.98 5.10 ± 1.61 4.96 ± 1.60 4.40 ± 2.28 4.41 ± 2.50 4.99 ± 2.04 0.017 T3, T4
   Fusobacterium nucleatum 7.57 ± 0.36 6.70 ± 0.62 6.82 ± 0.65 6.66 ± 0.80 7.01 ± 0.77 6.85 ± 0.95 <0.001 T1, T2, T3, T4, T5
Socransky's Red 6.02 ± 2.11 3.91 ± 2.55 3.72 ± 2.53 3.21 ± 2.74 3.63 ± 2.62 4.13 ± 2.45 <0.001 T1, T2, T3, T4, T5
   Porphyromonas gingivalis 1.17 ± 2.50 1.08 ± 2.28 1.08 ± 2.24 0.83 ± 2.00 0.89 ± 1.01 0.76 ± 0.62 0.242 T4, T5
   Tannerella forsythia 5.75 ± 1.93 3.57 ± 2.37 3.40 ± 2.36 3.00 ± 2.50 3.43 ± 2.39 3.58 ± 2.47 <0.001 T1, T2, T3, T4, T5
   Treponema denticola 3.47 ± 3.47 1.89 ± 2.83 2.02 ± 2.78 1.95 ± 2.81 1.78 ± 2.82 2.59 ± 3.02 <0.001 T1, T2, T3, T4, T5
Table 5. Evolution of Bacteria in the Socransky Complexes in the Test Sites. aBacteria (mean ± standard 
deviation) after LOG conversion (Log10 (count + 1)) of bacteria counts. bBy SUDAAN 7.0 (procedure 
REGRESS for global p-value and DESCRIPT for pairwise comparison only if global p-value is < 0.05) to 
account for clustering (multiple sites within the patient).
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within 30 min and do not cause health problems40. However, in some cases, these microorganisms impact distant 
sites provoking disease. Even if periodontal pathogens promote development of non-oral disease directly or indi-
rectly, migration of oral pathogens, related to the accumulation of biofilm, to the blood stream could also occur, 
causing higher risk to certain conditions4. Bacteremia has in fact been observed following some dental or medical 
procedures, and some bacteria were isolated from the blood after endodontic treatment. No relationship between 
the state of oral health and the incidence of bacteraemia due to dental extraction, toothbrushing and chewing 
was found41. The fact that the gingival tissue of the interdental space papilla neck is not keratinized reinforces the 
hypothesis of a metastatic spread of infection in the absence of gingivitis or periodontal disease. The particular 
histology of this area could also promote metastatic inflammation from the effects of circulating oral microbial 
toxins, and metastatic inflammation caused by immunological injury induced by oral microorganisms32. Thus, 
effective oral hygiene is a crucial factor in maintaining good oral health, which is associated with global health5.
Unfortunately, toothbrushing is ineffective in removing interdental biofilm even when the teeth are in a nor-
mal position42. Dental floss has been recommended for many years in conjunction with toothbrushing for remov-
ing dental plaque between teeth. IDBs have been developed for the same use, and many people find them easier to 
use than floss, providing there is sufficient space between the teeth43. However, to date, there is insufficient clinical 
evidence to determine whether interdental brushing reduces or increases the levels of plaque compared to floss-
ing and/or toothbrushing19. Moreover, all these studies focused on patients who have gingivitis or periodontitis. 
Consequently, interdental prophylaxis in clinically healthy subjects remains to be improved.
Individual oral clinical prophylaxis is actually based on mechanical disruption and not on elimination of the 
biofilm5. To disrupt interdental biofilms, the entire interdental space must be in contact with the IDB filaments12. 
The key factor in efficient interdental prophylaxis is the choice of an IDB whose diameter must correspond to that 
of the interdental space. In our study, a colorimetric interdental probe was used to choose the calibrated IDBs44. 
The clinical use of a calibrated colorimetric probe for the measurement of interdental space diameters definitely 
adds value for decision-calibrated IDB support and could permit better action for the disruption of interdental 
biofilms44.
Our study demonstrates that the use of IDBs in addition to toothbrushing decrease significantly the total 
number of bacteria at 4 weeks and 3 months and, re-establish the symbiotic microbiota by decreasing the quantity 
of bacteria associated with periodontal health (the purple, yellow and blue complexes) and decreasing the quan-
tity of bacteria associated with periodontal disease (the orange and red complexes). The toothbrushing alone per-
mit to stabilize the quantity of total bacteria and the quantity of bacteria from the yellow and the red complexes 
at 4 weeks and 3 months. So, the toothbrushing alone allows over a period of 3 months to maintain a microbiota 
Bacteria
Time
Basal (T0) 4 weeks (T4) 3 months (T5)
Total bacteria 0.286 0.004 0.273
Socransky's Blue (Actinomyces viscosus) 0.453 0.002 0.662
Socransky's Purple 0.269 0.027 0.339
   Veillonella parvula 0.138 0.040 0.282
   Actinomyces odontolyticus 0.360 0.036 0.851
Socransky's Green 0.590 0.956 0.968
   Eikenella corrodens 0.170 0.284 0.207
   Capnocytophaga sputigena 0.413 0.049 0.435
   Capnocytophaga ochracea 0.516 0.022 0.169
   Campylobacter concisus 0.652 0.725 0.602
   Aggregatibacter actinomycetemcomitans 0.158 0.095 0.118
Socransky’s Yellow 0.083 0.131 0.220
   Streptococcus mitis 0.068 0.002 0.100
   Streptococcus spp. 0.104 0.172 0.242
Socransky’s Orange 0.296 <0.001 <0.001
   Campylobacter gracilis 0.901 <0.001 0.054
   Campylobacter rectus 0.550 0.683 0.680
   Prevotella intermedia 0.741 0.108 0.132
   Prevotella nigrescens 0.927 <0.001 0.008
   Parvimonas micra 0.051 0.101 0.787
   Fusobacterium nucleatum 0.096 <0.001 <0.001
Socransky’s Red 0.531 <0.001 <0.001
   Porphyromonas gingivalis 0.819 0.043 0.036
   Tannerella forsythia 0.592 <0.001 0.002
   Treponema denticola 0.240 0.021 0.818
Table 6. Comparison of 50 Control and 50 Test Interproximal Sites after Follow-up in 25 Patients. The results 
are expressed as p-values obtained by SUDAAN 7.0 (procedure DESCRIPT) to account for clustering (multiple 
sites within the patient).
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whose composition and compatible with a periodontal health. This confirms that periodontal dysbiosis occurs 
over a broadened timeframe, which slowly turns the symbiotic association of host and microbe to pathogenic44.
Our results indicate that the quantity of total bacteria decreases within one week of use of IDBs. In particular, 
bacteria from the red and orange complexes i.e., virulent pathogens, are significantly decreased after one week 
of IDB use; the only exception was P. gingivalis, which significantly decreased after 4 weeks. This delay in the 
response time could be explained by the fact that this major agent in the incidence of periodontal disease can 
be resistant45. First, P. gingivalis can escape to the host defense mechanisms, particularly when it is organized 
into a biofilm46. In fact, P. gingivalis can deregulate the host immune system by producing a number of virulence 
factors, such as lipopolysaccharide, fimbriae, and several proteases47. Interestingly, T. denticola is known to pro-
duce succinate, which facilitates the growth of P. gingivalis48, and could be the first bacterium eradicated. Second, 
P. gingivalis can be difficult to eradicate even with the use of antimicrobials49. Ardila and colleagues demonstrated 
that P. gingivalis strains isolated from patients suffering from periodontitis can be resistant to penicillin, clinda-
mycin, amoxicillin, metronidazole, tetracycline, and azithromycin50. If antimicrobials are inefficient, periodonti-
tis becomes chronic, and surgical treatment becomes necessary46. The daily use of IDBs could be a simple means 
to help fight against P. gingivalis and the other periodontal bacteria from the orange and red complexes.
Many studies have reported a link between bacteria from the red and orange complexes and systemic dis-
eases50. For example, P. gingivalis, T. forsythia, F. nucleatum, and T. denticola can cause arteriosclerotic vascular 
diseases6. P. gingivalis in the respiratory mucosa increases the risk of developing aspiration pneumonia51. P. gin-
givalis, T. forsythia and P. intermedia are associated with poor glycemic control in diabetes mellitus patients52. 
Therefore, the daily use of calibrated IDBs, which leads to a decrease in the quantity of periodontal pathogens and 
interdental inflammation, could also be efficient in preventing some systemic diseases.
Concerning bacteria from the green complex, no significant effect was observed for C. sputigena and A. actino-
mycetemcomitans, whereas E. corrodens, C. ochracea and C. concisus were significantly decreased. E. corrodens was 
classified in a complex associated with microbiota symbiosis. E. corrodens might play an important role not only 
in healthy patients but also in the occurrence or progression of periodontitis in young patients53. C. ochracea and 
C. concisus are described in both healthy and diseased patients, underlying the possibility for strains to have dif-
ferent pathogenic potential54,55. Therefore, the pathogenic potential may differ depending on the anatomical site 
in the same host56. Depending on the ecological niche, bacteria adapt, leading to varying phenotypic expression 













Total bacteria −0.41 ± 0.07* 0.46 ± 0.16* 0.05 ± 0.01* 0.11 ± 0.11 0.05 ± 0.36
Socransky’s Blue (Actinomyces viscosus) 0.02 ± 0.26 0.64 ± 0.14* −0.05 ± 0.04 0.28 ± 0.36 −0.22 ± 1.19
Socransky’s Purple 0.04 ± 0.08 0.35 ± 0.13* 0.02 ± 0.02 −0.10 ± 0.20 0.22 ± 0.59
   Veillonella parvula 0.05 ± 0.08 0.30 ± 0.12* 0.02 ± 0.02 -0.14 ± 0.20 0.32 ± 0.63
   Actinomyces odontolyticus −0.16 ± 0.36 0.46 ± 0.10* 0.04 ± 0.04 0.05 ± 0.32 0.93 ± 1.33
Socransky’s Green −0.05 ± 0.12 0.51 ± 0.13* 0.06 ± 0.02* −0.00 ± 0.17 0.85 ± 0.71
   Eikenella corrodens 0.11 ± 0.18 0.59 ± 0.15* 0.05 ± 0.03 0.01 ± 0.26 0.66 ± 1.04
   Capnocytophaga sputigena 0.08 ± 0.22 0.40 ± 0.26 0.09 ± 0.05 −0.17 ± 0.46 3.08 ± 2.53
   Capnocytophaga ochracea −0.57 ± 0.30 0.76 ± 0.16* 0.01 ± 0.05 −0.38 ± 0.48 −0.91 ± 1.55
   Campylobacter concisus 0.10 ± 0.22 0.29 ± 0.11* 0.05 ± 0.03 −0.17 ± 0.31 −0.68 ± 1.04
   Aggregatibacter actinomycetemcomitans −0.05 ± 0.17 0.77 ± 0.07* 0.03 ± 0.03 0.21 ± 0.17 −0.05 ± 0.55
Socransky’s Yellow 0.09 ± 0.11 0.39 ± 0.14* 0.03 ± 0.02 0.03 ± 0.19 0.68 ± 0.69
   Streptococcus mitis 0.11 ± 0.10 0.38 ± 0.13* 0.03 ± 0.02 −0.02 ± 0.20 1.25 ± 0.80
   Streptococcus spp. 0.09 ± 0.11 0.39 ± 0.14* 0.04 ± 0.02 0.04 ± 0.19 0.66 ± 0.72
Socransky’s Orange −0.60 ± 0.13* 0.63 ± 0.10* 0.06 ± 0.01* −0.09 ± 0.13 −1.40 ± 0.40*
   Campylobacter gracilis −0.58 ± 0.31 0.43 ± 0.19* 0.05 ± 0.03 −0.41 ± 0.31 −0.94 ± 1.38
   Campylobacter rectus 0.17 ± 0.32 0.55 ± 0.13* 0.02 ± 0.03 −0.23 ± 0.40 1.01 ± 1.14
   Prevotella intermedia −0.90 ± 0.48 0.40 ± 0.10* 0.13 ± 0.05* 0.04 ± 0.47 −2.54 ± 1.57
   Prevotella nigrescens −0.97 ± 0.33* 0.46 ± 0.08* 0.16 ± 0.04* 0.15 ± 0.36 0.48 ± 1.01
   Parvimonas micra -0.29 ± 0.26 0.63 ± 0.10* 0.10 ± 0.03* 0.60 ± 0.38 -0.24 ± 1.11
   Fusobacterium nucleatum −0.65 ± 0.14* 0.52 ± 0.20* 0.07 ± 0.02* −0.12 ± 0.17 −1.37 ± 0.52*
Socransky’s Red −1.00 ± 0.27* 0.77 ± 0.13* 0.13 ± 0.05* 0.19 ± 0.41 −3.00 ± 1.14*
   Porphyromonas gingivalis −0.92 ± 0.13* 0.58 ± 0.08* 0.01 ± 0.02 0.03 ± 0.24 −1.78 ± 0.91
   Tannerella forsythia −1.10 ± 0.35* 0.70 ± 0.14* 0.14 ± 0.05* 0.32 ± 0.45 −1.60 ± 1.43
   Treponema denticola −0.71 ± 0.24* 0.54 ± 0.08* 0.14 ± 0.07* −0.14 ± 0.62 −9.11 ± 2.19*
Table 7. Analysis of Factors Impacting the Modification of Bacteria. Multiple regression modelsa (one model 
per bacterial countb at the end of follow-up −3 months- as the dependent variable, -first column-). Data from 
100 interproximal sites from 25 patients. Predictor variables (first line) are forced into the models. aBy SUDAAN 
7.0 (procedure REGRESS) to account for clustering (multiple sites within the patient). bBacteria after LOG 
conversion (Log10 (count +1)) of bacteria counts. *p < 0.05. 
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Bacteria from the blue, purple and yellow complexes, which are associated with oral health, increase over 
time with the daily use of IDBs. Our results demonstrate that, with the daily use of IDBs, the proportion of 
bacteria associated with good oral health increased, whereas bacteria associated with periodontal disease 
decreased. Moreover, these results are associated with a decrease in interdental inflammation. Therefore, the 
use of calibrated-diameter IDBs appears to be a key factor in disturbing the interdental biofilm and restoring the 
symbiosis of the microbiota.
Our study has several limitations. First, a targeted group of virulent bacteria has been identified mainly 
because of historical evidence of their ability to differentiate periodontitis from health. A subsequent prospective 
longitudinal experimental design in conjunction with a broader panel of bacteria could be necessary to demon-
strate the prognostic ability of IDBs and link bacteria to non-oral diseases. Therefore, some of these results can 
only be considered exploratory, and a direct connection between local and systemic immunological factors can-
not be assumed. A more detailed study that explicitly accommodates the various factors that can contribute to 
patient-specific variations may be necessary to assess the individual contributions of these factors. Further studies 
should follow-up on the immunological and microbiological results to characterize the connection between sys-
temic factors and local factors in the periodontium more precisely.
Despite these limitations, this study is unique. We conducted a cohort study involving clinically healthy 
patients performed by professional dentists using the same criteria to minimize the errors introduced by clinical 
diagnosis and bacterial samples. One of the main strengths of this study is that we included well-defined cohorts 
with a number of sites adapted to the use of the PCR method and the incidence of virulent bacteria in healthy 
adults. Second, our study investigated a large number of sites to reflect a close-to-real-life-picture of the utiliza-
tion of IDBs. The potential confirmation that natural gingival inflammatory processes are extravascular stimuli 
triggering systemic inflammation could have great public health implications.
In this context, our clinical results should introduce new clinical and public health perspectives.
In the short term, the daily use of IDBs could lead to the reestablishment of symbiotic interdental microbiota 
and the disappearance of interdental inflammation by decreasing periodontal pathogens. This could also contrib-
ute to reestablishing symbiosis of the salivary and oral microbiota.
In the medium term, this method could significantly reduce the incidence and/or severity of periodontal 
diseases. Toothbrushing is the cornerstone of dental health education to prevent periodontal disease, while also 
emphasizing the need to systematically clean all interdental tooth surfaces58. In fact, 90% of adults in industrial-
ized countries report brushing twice a day59. However, the incidence of severe periodontitis in 2016 was 89 840 
000 cases1. This prophylactic approach may be important in preventing and controlling chronic periodontitis by 
preventing growth and colonization by periodontal pathogens and decreasing inflammation.
In the long term, the daily use of calibrated IDBs should contribute to reducing risk, morbidity and mortality 
mainly related to systemic diseases such as cardiovascular diseases, diabetes, cancers and chronic respiratory 
diseases. To improve this hypothesis, long-term prospective cohort studies are needed.
conclusions
In this article, we performed a microbiological evaluation of a prophylactic technique used to reduce the inci-
dence of periodontitis and systemic disease. This field of research is especially relevant considering the increasing 
morbidity and relatively high mortality previously discussed. Our study contributes to the production of infor-
mation regarding strategies and research investigating the reduction of inflammation characteristic to specific 
health conditions.
Therefore, benefits in terms of oral prophylactic behaviors and general health should be observed considering 
the positive impact of using calibrated IDBs.
Effective collaboration that supports prophylactic activity must include participation by the whole commu-
nity, including health professionals, dentists, patients and the wider community, and be focused on achieving 
results. In summary, calibrated interdental brushes are a great alternative to flossing that dental professionals can 
offer to patients to improve their health.
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